Brief: A1M Pharma Enters Into Collaboration With Antaros Medical

Disruptive Pharma AB (publ)

05/01/2018 07:10

Jan 5 (Reuters) - A1M PHARMA AB  A1M.ST : 
    * A1M PHARMA INITIATES ITS CLINICAL PROGRAM - ENTERS INTO 
COLLABORATION TO STUDY HARMFUL EFFECTS DURING PRRT RADIATION 
THERAPY 
    * STUDY IS SCHEDULED TO START DURING Q1 OF 2018, AND IT IS 
EXPECTED TO BE COMPLETED IN LAST QUARTER OF 2019 
    * HAS INITIATED A COLLABORATION WITH ANTAROS MEDICAL 
 
Source text for Eikon:  ID:nBQN9S7jXT  
Further company coverage:  A1M.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))